A detailed history of Symphony Financial Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Symphony Financial Services, Inc. holds 583 shares of LLY stock, worth $485,924. This represents 0.27% of its overall portfolio holdings.

Number of Shares
583
Previous 628 7.17%
Holding current value
$485,924
Previous $519 Million 12.3%
% of portfolio
0.27%
Previous 0.34%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$713.71 - $898.95 $32,116 - $40,452
-45 Reduced 7.17%
583 $455 Million
Q1 2025

May 12, 2025

SELL
$725.72 - $929.72 $106,680 - $136,668
-147 Reduced 18.97%
628 $519 Million
Q4 2024

Feb 06, 2025

SELL
$727.2 - $932.06 $213,069 - $273,093
-293 Reduced 27.43%
775 $597 Million
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $135,896 - $168,963
176 Added 19.73%
1,068 $859 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $646,584 - $810,863
892 New
892 $906 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $792B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Symphony Financial Services, Inc. Portfolio

Follow Symphony Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symphony Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Symphony Financial Services, Inc. with notifications on news.